Related Experiment Videos
Body surface area estimation in children using weight alone: application in paediatric oncology
Insights
Accurate pediatric chemotherapy dosing is simplified with a new body surface area (BSA) estimation method using only weight. This approach, showing less than 10% deviation, offers a reliable alternative for calculating drug dosages in children.
Area of Science:
- Pediatric Oncology
- Pharmacokinetics
- Biostatistics
Background:
- Chemotherapy drug dosages are typically standardized using body surface area (BSA).
- Accurate BSA estimation in pediatric patients is challenging due to reliance on height and weight measurements.
- Existing nomograms pose difficulties for precise BSA calculation in children.
Purpose of the Study:
- To evaluate a novel method for estimating body surface area (BSA) in pediatric patients using weight alone.
- To compare the accuracy of the weight-based BSA estimation against conventional methods.
- To provide a more reliable approach for standardizing chemotherapy doses in children.
Main Methods:
- The chemotherapy standards group of the UKCCSG evaluated a BSA estimation formula based solely on patient weight.
- BSA estimates from the new method were compared against two common methods requiring both weight and height.
- The deviation between the weight-based BSA estimate and conventional methods was analyzed.
Main Results:
- The weight-based BSA estimation method demonstrated a deviation of less than 10% compared to conventional methods.
- This method shows potential for application in dosing chemotherapeutic agents in infants under 10 kg.
- The formula provides a robust and reliable calculation of BSA from weight alone.
Conclusions:
- A weight-based BSA calculation offers a viable and accurate alternative for pediatric chemotherapy dosing.
- This method simplifies dosage standardization, particularly when height measurement is difficult.
- Caution is advised when applying this method to children under 10 kg, obese patients, or those with cachexia.
Abstract:
The majority of chemotherapy regimens and trials specify doses of cytotoxic drugs normalized to body surface area. Estimation of BSA in paediatric patients is particularly problematic, as conventional nomograms require accurate determination of both height and weight. The chemotherapy standards group of the UKCCSG (United Kingdom Children's Cancer Study Group) has evaluated a method for calculation of body surface area (BSA) estimation, based solely on patient weight. In comparison with BSA estimations using 2 commonly used methods, which require both weight and height measurements, deviation in the estimate of BSA was less than 10%. This method may be extended to the dosing of chemotherapeutic agents in infants of body weight less than 10 kg, with appropriate recommendations for dose modification. Until better correlates of drug clearance, such as GFR for carboplatin, are identified BSA is used to standardize doses for most chemotherapeutic agents. The formula presented here provides a more robust and reliable method of calculation of BSA from weight alone. Although this approach has been shown to be equivalent to other currently used methods, care should be taken extending this calculation of BSA to children less than 10 kg, to obese patients and to those with cachexia.